Der er blevet rapporteret reversibel øgning af serum- lithiumkoncentrationer og toksicitet ved samtidig administration af lithium og angiotensin- konverterende enzymhæmmere.
Lithium: reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin converting enzyme inhibitors.